Stock Market News Briefs: Estee Lauder Companies, Gilead Sciences, Genworth Financial Inc, Idenix Pharmaceuticals, Sony Corporation
- Estee Lauder Companies, Inc.’s (NYSE:EL) second quarter 2012 quarterly earnings increased 17% year over year to $1.00 per share, but missed the Zacks Consensus Estimate of $1.01 by a penny
- After concerns arose that Idenix Pharmaceuticals, Inc.’s (NASDAQ:IDIX) hepatitis C drug would be unable to compete with Gilead Sciences, Inc. (NASDAQ:GILD) drug, shares of Idenix declined by 11.5%
- Genworth Financial Inc’s (NYSE:GNW) fourth quarter operating income came in at $0.17 per share, in line with the Zacks Consensus Estimate
- Sony Corporation (NYSE:SNE) reported that it has laid off 100 employees over the past few weeks
ESTEE LAUDER (EL): Free Stock Analysis Report
Enter your E-mail address to subscribe to DailyMarkets.com for FREE
Best Credit Cards
Chase Freedom- Blue Cash
- Chase Sapphire
- American Express Platinum Card
- United Credit Card
- Southwest Credit Card
- Delta Credit Card
- British Airways Card - Get 100,000 Bonus Points
- Blue Cash Preferred
- Capital One Venture
- Discover Card
- Chase Ink Credit Card
- Discover More Card - 18 Month Promotional Balance Transfer
- Chase Sapphire Preferred
- Ritz-Carlton Rewards Credit Card
- Citi Diamond Preferred Card
- American Express Premier Rewards Gold Card
- Starwood Preferred Guest
- American Express Gold Card
- Citi Dividend
- Capital One Cash Rewards
- Discover Student
- Marriott Rewards Credit Card
- Marriott Rewards Premier Credit Card
- Capital One Secured Credit Card
- Hilton Rewards
- Credit Card Rewards
Broker Reviews